Inactive Instrument

Other languages CEL-SCI Corporation Nyse

Equities

US1508375086

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine	05-08
CEL-SCI Corporation Announces Significantly Positive Outcome from its Recent Meeting with U.S. Food and Drug Administration Regarding Path to Approval for its First-Line Investigational Cancer Immunotherapy Multikine	05-08
CEL-SCI Corporation Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer	05-08
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	04-23
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	02-14
CEL-SCI Corporation (von First Berlin Equity Research GmbH...	02-14
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	02-09
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	02-06
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	01-31
Sector Update: Health Care Stocks Gain in Afternoon Trading	01-31
Cel-Sci Receives Pediatric Requirements Waiver for Multikine From European Medicines Agency	01-31
CEL-SCI Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	12-21
CEL-SCI Corporation (von First Berlin Equity Research GmbH...	12-05
CEL-Sci Corporation Releases Video Detailing Recent Phase 3 Findings & Its Plans to Seek Immediate Regulatory Approvals	23-10-24
Sector Update: Health Care Stocks Softer Late Afternoon	23-10-23
Sector Update: Health Care	23-10-23
Top Midday Gainers	23-10-23
CEL-SCI Presents the Data for the First Time at the European Society for Medical Oncology Congress in Spain	23-10-23
CEL-SCI Corporation Readies Its Multikine Manufacturing Facility for Commercial Scale Production	23-10-19
Cel-Sci Files Request with the Uk's Mhra Regarding Path to Approval for Multikine in the Treatment of Head & Neck Cancer	23-10-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CEL-SCI Corporation Nyse

Equities

US1508375086

Other languages

Filters